<div>Kevin Buckley, founder of Torrey Pines Law Group, and Neil Thompson, a patent agent with the firm, discuss IP strategy as it relates to pharma and artificial intelligence.</div>

Kevin Buckley, founder of Torrey Pines Law Group, and Neil Thompson, a patent agent with the firm, discuss IP strategy as it relates to pharma and artificial intelligence.

Episode 77: The Effects of AI on IP

<div>The Pharm Exec Podcast goes beyond the pages of the Pharmaceutical Executive print magazine and <a href="http://PharmExec.com">PharmExec.com</a> to bring the latest commercial insights to the C-suite through in-depth interviews. Podcast episodes examine current trends, key conferences, and critical topics in the industry. </div>

Science

Life Sciences

The Pharm Exec Podcast goes beyond the pages of the Pharmaceutical Executive print magazine and PharmExec.com to bring the latest commercial insights to the C-suite through in-depth interviews. Podcast episodes examine current trends, key conferences, and critical topics in the industry.

The Pharm Exec Podcast goes beyond the pages of the Pharmaceutical Executive print magazine and <a href="http://PharmExec.com" rel="noopener noreferrer">PharmExec.com</a> to bring the latest commercial insights to the C-suite through in-depth interviews. Podcast episodes examine current trends, key conferences, and critical topics in the industry.&nbsp;

Share Episode 77: The Effects of AI on IP

Sign up to save your podcasts

Episode 77: The Effects of AI on IP

Episode 77: The Effects of AI on IP

More shows like Pharmaceutical Executive

Planet Money

Economist Podcasts

Motley Fool Money

WSJ Your Money Briefing

WSJ What’s News

Bloomberg Businessweek

WSJ Tech News Briefing

HBR IdeaCast

Bold Names

The Indicator from Planet Money

The Readout Loud

Thoughts on the Market

The Journal.

Bloomberg Daybreak: US Edition

WSJ's Take On the Week